420 with CNW – New Mexico Makes Sweeping Changes to its Medical Cannabis Law

Ever since the Compassionate Use Act was signed into law in 2007, no major changes had been made to it until last week when Gov. Michele Grisham appended her signature to Senate Bill 406. This bill, now a law, makes numerous changes to the medical cannabis law of New Mexico.

One major change that will take effect on June 14 has to do with medical cannabis in schools. Under the updated law, medical cannabis will be administered on school premises under specific circumstances. For this to happen, parents of kids on medical cannabis will present to the school a detailed treatment plan designed by a medical professional.

However, schools will still reserve the right to accept or outlaw medical marijuana if the school district thinks that their federal funding may be at risk.

The new changes to the law will also allow patients who have a license to grow their own medical marijuana to take their produce to a manufacturer for processing into edibles, concentrates or any other form desired by the patient. This will, of course, be at the expense of the patient.

Previously, only Non-Profit producers of medical marijuana could take it to manufacturers for processing.

Medical cannabis users from other states also have a reason to smile after the governor signed this bill. Out-of-state medical cannabis users will now be able to take part in the medical marijuana program of New Mexico. Previously, only residents could benefit from this program.

The validity period of medical cannabis cards issued by New Mexico has also been extended from one year to three years. This will save the time and expenses associated with renewing a card each year.

It has also been hard for patients to find a place outside their homes where they can consume medical cannabis. The new law intends to put an end to this since it contains provisions for the licensing of consumption areas. The only condition here is that those consumption areas have to be approved by the New Mexico Department of Health.

The law has provisions that cement the protections accorded to patients using medical cannabis. For example, a patient will not be fired from a job just because he or she uses medical cannabis. However, this protection doesn’t save you from being fired if you are under the influence while at your job. Similarly, a parent will not be denied visitation or custody rights on account of being a user of medical cannabis.

The entire cannabis industry, including Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), welcomes the updates which have been made to the cannabis law in New Mexico in order to bring the law in line with the evolving needs of the patients using medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Mainstream Acceptance, Strong Growth Adds to Growing CBD Market

CannabisNewsWire Editorial Coverage: The CBD market is experiencing explosive growth as a result of growing mainstream acceptance and strong leadership.

  • The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
  • Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
  • Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.

Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Several companies are responding to the growth by expanding operations. Canadian-based Tilray Inc. (NASDAQ: TLRY) is adding production capacity in both Canada and Europe. Aphria (NYSE: APHA) (TSX: APHA) is increasing its indoor grow operations. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is focusing its development efforts on projects in the United States. And Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is using a significant outside investment to make…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – California Bill Aims to Allow Terminally Ill Patients to Use Marijuana in Hospitals

Senate Bill 305, also called The Compassionate Access to Cannabis Act, has been tabled (this week) before a Senate Committee in California. The bill is intended to allow patients who are terminally ill to access medical marijuana while they are in hospital or other care facilities.

The bill is also referred to as “Ryan’s Law.” Ryan Bartell lost his life to pancreatic cancer at 42 years of age last year. After he was diagnosed with the disease, Ryan received high doses of prescription opiates in the Washington-based facility where he was admitted.

His family wanted to switch to cannabis, but they were dismayed to learn that the hospital where Ryan was admitted could not accept the use of cannabis on its premises. The Cannabis Nurses Network came to the rescue of the family and helped them to move the patient to another hospital where he could receive cannabis medications.

The cannabis medications produced astonishing results because Ryan remained alert and pain-free throughout his final days. In contrast, the opiates he had previously been taking kept him barely conscious and the pain didn’t go away.

Upon the death of Ryan, his father (Jim Bartell) hired a lawyer to help him to draft The Compassionate Access to Cannabis Act in memory of his son. Jim Bartell didn’t want other patients to be restricted to opiates that would deny them the chance to have some quality time with their families in their final days.

The federal Drug-Free Workplace Act compels all institutions that receive funding from the federal government to prevent the distribution and use of controlled substances, such as marijuana.

The bill before California’s senate committee wants to provide a way for medical facilities to put in place mechanisms by which patients receiving end-of-life care can, upon the recommendation of their doctor, access cannabis within the healthcare facility.

The bill will prevent a scenario in which hospitals scramble to find a way to provide medical marijuana. Instead, they will plan ahead so that once a patient or their doctor requests for medical cannabis, then the hospital would simply activate the system that they had established proactively.

If enacted, the bill will play a big role in bringing medical marijuana into the mainstream as far as the field of medicine is concerned. The stigma against medical marijuana can reduce drastically with this one measure.

VPR Brands, LP (OTC: VPRB) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) earnestly hope that Ryan’s Law is passed so that medical cannabis takes its rightful place among the treatments that patients can receive while in hospital.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Federally Grown Cannabis is Closer to Hemp than Commercially Available Cannabis, Study Finds

According to newly published research, the research-grade cannabis sourced from the only federally licensed cultivator (Mississippi University) is closer to hemp than the commercially available cannabis in the states where cannabis is legal.

The findings of this research bring into question the outcomes of the marijuana studies which have been conducted using the cannabis from the Mississippi farm. Do the results really help researchers to understand the real-world effects of cannabis?

Earlier research had demonstrated that the marijuana grown at the University of Mississippi using funds obtained from NIDA (National Institutes on Drug Abuse) had lower concentrations of THC and CBD when compared to the cannabis products that are commercially available.

However, the researchers from the University of Northern Colorado wanted to go a step further and compare the genetic composition of the federally-approved cannabis and what is on the market in states where cannabis is legal.

The researchers therefore obtained about 49 samples of hemp and cannabis taken from what is on the market and what NIDA avails to federally-approved research teams. The samples included sativa, indica and hybrid varieties of marijuana currently available on the market.

After analyzing these samples, the research team was surprised to find that the cannabis supplied by NIDA differed so much from what was on the market. The research-grade cannabis proved to be genetically closer to hemp rather than being similar to the cannabis consumers were accessing legally.

This outcome provides food for thought when one is thinking about using cannabis from NIDA to do research. If the research is focused on THC or CBD as standalone components, then the cannabis from Mississippi University can suffice.

However, if the study is intended to understand what effects cannabis has on the patients or recreational users, then the NIDA products aren’t appropriate since their use won’t mirror what people are consuming.

The findings of this Colorado study provide more momentum to the calls for expanding the federally-approved cultivators of research-grade cannabis in the U.S. While calls for interested parties to cultivate cannabis for research purposes were published, the Department of Justice has been very slow in processing the applications, so Mississippi University is still the sole federal source of cannabis for research purposes.

William Barr, the new U.S. Attorney General, has promised to look into the matter and take the necessary steps. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) hope that the research from the University of Northern Colorado triggers a sense of urgency in bringing more cultivators on board so that researchers can access cannabis of the right quality.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Guam Legalizes Recreational Cannabis

Lou Leon Guerrero, the Governor of Guam, has signed into law a bill that legalizes recreational cannabis in the U.S. territory. This signing comes after months of intense debate in this small Pacific island of 164,000 residents.

The law provides for the creation of a nine-member Cannabis Control Board which will draft the rules governing retail sales. The rules are scheduled to be drafted and debated in the course of this year. This board will also oversee the entire recreational cannabis program.

Under the newly passed legalization law, adults in Guam will be permitted to possess a maximum of an ounce of cannabis. Residents will also be allowed to grow six mature plants for their own recreational use.

Speaking at a press conference, Guerrero said that cannabis is the most used illicit drug, so the law was needed in order to regulate its use in order to protect minors and also benefit from its medicinal properties. She added that the new law will create a safer environment for the residents of the island territory.

It should be noted that Guam legalized medical marijuana back in 2014. However, the island has never licensed a testing lab, so the medical marijuana sector remains largely dormant. Home cultivation of recreational marijuana was also approved in 2018.

It is hoped that the legalization of recreational cannabis will add impetus to the efforts to operationalize the commercialization of cannabis both for medicinal and recreational purposes.

The cannabis law was passed without any stiff opposition. The only concern that was raised by some legislators regarded the federal status of cannabis. However, this matter was put to rest when supporters pointed out that the STATES Act was making its way through committees of Congress and this showed that the federal government would not interfere in any jurisdiction that had passed its own marijuana laws.

The STATES Act largely centers on making it possible for marijuana businesses to get access to banking and insurance services without any fear of federal repercussions upon the banks, credit unions and insurance companies that choose to do business with marijuana companies in the U.S. states and territories where marijuana is legal in some form.

The signing of the legalization bill makes Guam the second U.S. territory to legalize recreational marijuana. Northern Mariana Islands was the first territory to allow adult-use cannabis when it passed its cannabis law last year.

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and Sugarmade, Inc. (OTCQB: SGMD) welcome Guam into the fold of jurisdictions that have enacted laws to regulate the cannabis industry in order to tap the opportunities presented by this nascent sector.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Another Connecticut Legislative Committee Approves Cannabis Legalization

The Judiciary Committee in Connecticut’s Assembly has also approved a bill that will pave the way for marijuana legalization. This is after the General Law Committee also approved a bill on cannabis legalization.

The move to legalize recreational cannabis in Connecticut is still in its early stages, and the legislators have opted to draft different bills covering different aspects of legalization before merging all those bills into one once they are passed by the relevant committees.

The bill before the Judiciary Committee was hotly contested and it passed with a slim majority (21 votes in favor and 19 against).

If the bill becomes law, adults who are 21 or older would be allowed to possess a maximum of 1.5 ounces of cannabis and a maximum of 5 grams of cannabis concentrates. The bill outlaws the home cultivation of cannabis.

During the meeting of the Judiciary Committee, some members expressed concerns about the possible effects of cannabis legalization on impaired driving and youth consumption. However, many of these individuals acknowledged that voting against the bill would be a futile undertaking since cannabis legalization was inevitable.

The bill eventually passed, and it is now headed to the Finance Committee. Thereafter, the different bills will be combined into one prior to being tabled before the entire legislative assembly for consideration.

Cannabis advocates generally support the bill, although they suggest that it should be improved in several aspects.

One area of improvement suggested by the Marijuana Policy Project has to do with the expungement provisions. The advocates suggest that all prior cannabis convictions should be expunged. They also want the bill to include a provision that allows residents to grow their own recreational marijuana.

Other advocates also want the law to be clear about the way in which the different communities that suffered the brunt of the so-called war on drugs can benefit from the opportunities created in the legal cannabis industry.

As things stand, both sides on this debate may have to make concessions if the bill is to have a chance of becoming a law soon. Otherwise, a lack of consensus and compromise may create a situation similar to what has played out in New York State where adult-use cannabis could not be included in the state budget due to disagreements regarding the way in which the legalization policy would be implemented.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and SinglePoint Inc. (OTCQB: SING) hope that the path to cannabis legalization gets smoother as the different bills leave the different House Committees in Connecticut.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Increasing Growth, Acceptance Move CBD Market Toward Mainstream

CannabisNewsWire Editorial Coverage: The CBD market is seeing strong growth and a move towards the mainstream.

  • The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
  • Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
  • Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.

Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Focused on the organic market, Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) has significantly increased its output to meet demand. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has earned its CEO industry-wide recognition through strong growth and a powerful place as a market leader. HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) is pushing CBD and cannabis toward the mainstream through connections with food and consumer product companies. Significant developments in science and agriculture, where Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) is making great steps forward in developing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Israel Decriminalizes Recreational Cannabis

New cannabis laws that were passed in Israel on April 1 decriminalize recreational cannabis. This means that people found with small amounts of cannabis will be fined instead of facing criminal charges if those individuals don’t have a license to use medical cannabis.

The day when adult-use marijuana was decriminalized was also the day when the fourth edition of the annual CannaTech conference was held in Tel Aviv. Ehud Barak, a former Israel premier, spoke eloquently at the CannaTech conference about the immense benefits of medical cannabis. He went as far as saying that the Israeli motto may be updated to “the land of milk, honey and cannabis.”

Why would Ehud Barak deliver a keynote address at a cannabis conference? It so happens that the former premier is the chairman of an Israeli medical marijuana company called Canndoc/Intercure.

Barak joins a growing list of politicians who previously opposed cannabis but are now ardent advocates. He joins the likes of former speaker of Congress, John Boehner. Vicente Fox, the former president of Mexico, also changed from being a kingpin in the fight against marijuana to calling for an overhaul of prohibitionist marijuana laws.

Ehud Barak pointed out during his keynote address that the future of marijuana belonged to the bigger and more assertive players who would “swiftly enter the cannabis market.”

He was referring to the decision of the Israeli parliament that passed a law in December last year paving way for Israeli companies to export medical marijuana. This law positioned Israel to be one of the biggest players in the international marijuana industry.

Barak also talked about Israeli cannabis companies like Tikun Olam (a Hebrew expression meaning “repair the world”) that already had a major stake in the cannabis market. This company alone commands an estimated 40 percent share of the global medical cannabis industry.

His statements should not be taken lightly, because major milestones, such as the discovery of the endocannabinoid system in humans, can be traced to Israeli doctors or researchers.

Meanwhile, the Ministry of Health in Israel has revealed that more than 550 farms in the country have submitted their applications for licenses to grow medical cannabis. There is no guessing which market these cultivators are eyeing, since the local market cannot utilize all the cannabis grown by these farms.

Israel has a short list of qualifying conditions for which patients can get a prescription for medical marijuana. These include epilepsy, Parkinson’s, cancer and many other terminal illnesses. Most of the medical cannabis grown in Israel is therefore likely to be headed out of the country.

MustGrow Biologics Corp. and Net Element, Inc. (NASDAQ: NETE) congratulate Israel upon taking the important step of decriminalizing recreational cannabis. The next step should now be full legalization.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Student-Organized Event Discusses Cannabis on Sidelines of Michigan Hash Bash

Every year, a Hash Bash festival is held in Ann Arbor as a day of having fun and entertainment. This year, law students at Michigan Law School worked with the organizers of the Hash Bash festival to host an event at the law school to discuss marijuana legalization politics.

This event was held yesterday (Sunday, April 7) while the Hash Bash took place on Saturday. The organizers of the event at Michigan Law School wanted to educate members of the public about issues related to marijuana. Several panelists made presentations on various issues.

Ari Goldstein, a law student who was one of the organizers, remarked that marijuana legalization brings entrepreneurial opportunities that haven’t been seen since the Great Depression, so every effort must be taken to prepare people to seize those opportunities.

Kevin Boehnke, who is a research fellow at Michigan University’s Department of Anesthesiology, revealed during his presentation that several patient studies point to the fact that more patients are opting for medical marijuana to manage pain instead of using prescription opioids.

The shift is due to the better symptom relief experienced by patients, and the concerns about the documented side effects of prescription opioids.

Another panelist, Gus Rosania (a professor of pharmacological sciences) handled the topic of natural vs. synthetic cannabis ingredients. Rosania dispelled the misconception that synthetic cannabis is different from natural cannabis.

He revealed that at the basic level, synthetic marijuana is chemically identical to natural marijuana, so it is hard to tell the two apart. He added that it was only because different ingredients could be isolated and made in a lab that it was possible to identify the different cannabinoids in marijuana.

Andrew Brisbo, the head of Michigan’s Bureau of Marijuana Regulation, was also in attendance to talk about the ramifications of the legalization of recreational cannabis in the state. He revealed that he had a huge task on his desk to put together a program for recreational cannabis implementation in just a year from the time the law was passed.

Brisbo intimated that one way that he was using to get everything done correctly is by engaging different stakeholders in order to tap their perspectives when putting together an implementation plan.

Many people in the audience expressed their frustration about how hard it was for them to get a medical cannabis prescription from their doctors. Brisbo expressed sympathy for their plight and revealed that it wasn’t easy to change attitudes about cannabis after such a long time of prohibition. He added that efforts were underway to give physicians more information about medical cannabis so that they can gradually warm up to prescribing it to their patients who qualify for such treatment.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America, Inc. (OTCQB: MCOA) welcome such engagements between regulators, patients, professors and other stakeholders since such interactions can result in better cannabis industry policies.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Florida Moves to Regulate the Potency of Smokable Medical Cannabis

Barely a month ago, Gov. DeSantis signed a bill to allow patients to smoke medical marijuana after protracted legal battles which ended when court ruled that banning smokable marijuana was unconstitutional. Now a bill to regulate the strength of the smokable medical marijuana has been passed by a House committee amidst protests by medical cannabis advocates.

On Wednesday (April 3), the Health and Human Services Committee decided that the THC content of the marijuana flower that patients wish to smoke should not exceed 10 percent.

Medical cannabis advocates protested, saying that such a cap didn’t even reflect the strength of the cannabis already on the market. The advocates say that higher THC levels are necessary for triggering the therapeutic effects that patients have been enjoying when they use medical marijuana.

The advocates also say that the cap will make medical cannabis more expensive since patients may need to buy more in order to get the effects that they were getting when using more potent cannabis.

Those against this cap also say that the state has just handed a lifeline to the black market since patients are likely to shun legal weed in favor of more potent marijuana on the black market.

In general, the Republicans on the committee were in favor of the cap while the Democrats didn’t want the limit to be passed.

Ray Rodrigues, the chair of the committee, argued that there was research showing that marijuana with a THC concentration that is higher than 10 percent can cause psychosis in some patients while marijuana with less than 10 percent THC content was therapeutic.

He rejected calls for Florida to first study the effects of higher levels of THC on patients before imposing such a cap. The chairman responded that while medical cannabis was relatively new in Florida, it had been around for decades in other states, and the data there shows that high THC levels can be problematic.

Out of the 33 states and the District of Columbia where medical cannabis is legal, 14 have THC limits on medical marijuana. Rodrigues said that most of those 14 states impose a limit that is much lower than what is being proposed in Florida.

Currently, more than 200,000 people have medical cannabis identification cards in Florida. It is not clear how the THC limit will affect their buying habits, and whether more people will enroll for the program.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Green Hygienics Holdings Inc. (OTCQB: GRYN) hope that more robust debate will be conducted when this proposed bill is tabled before the entire House prior to its passing so that the limit set doesn’t push patients to the black market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com